首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
delivery combined with borderline tumor相关文献:
A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
Parikh PJ, Lee P, Low DA, Kim J, Mittauer KE, Bassetti MF, Glide-Hurst CK, Raldow AC, Yang Y, Portelance L, Padgett KR, Zaki B, Zhang R, Kim H, Henke LE, Price AT, Mancias JD, Williams CL, Ng J, Pennell R, Pfeffer MR, Levin D, Mueller AC, Mooney KE, Kelly P, Shah AP, Boldrini L, Placidi L, Fuss M, Chuong MD.
Int J Radiat Oncol Biol Phys. 2023 Nov 15;117(4):799-808. doi: 10.1016/j.ijrobp.2023.05.023. Epub 2023 May 19.
PMID:37210048
Therapeutic Advances in Localized Pancreatic Cancer.
Tsai S, Evans DB.
JAMA Surg. 2016 Sep 1;151(9):862-8. doi: 10.1001/jamasurg.2016.1113.
PMID:27276001
Ovarian cancer during pregnancy.
Gezginç K, Karataylı R, Yazıcı F, Acar A, Celik C, Capar M.
Int J Gynaecol Obstet. 2011 Nov;115(2):140-3. doi: 10.1016/j.ijgo.2011.05.025. Epub 2011 Aug 26.
PMID:21872237
Radiation therapy in borderline resectable pancreatic cancer: A review.
Turner KM, Delman AM, Kharofa JR, Smith MT, Choe KA, Olowokure O, Wilson GC, Patel SH, Sohal D, Ahmad SA.
Surgery. 2022 Jul;172(1):284-290. doi: 10.1016/j.surg.2021.12.013. Epub 2022 Jan 13.
PMID:35034793
Total Neoadjuvant Therapy for Operable Pancreatic Cancer.
Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S.
Ann Surg Oncol. 2021 Apr;28(4):2246-2256. doi: 10.1245/s10434-020-09149-3. Epub 2020 Sep 30.
PMID:33000372
Advances in early diagnosis and therapy of pancreatic cancer.
Xu Q, Zhang TP, Zhao YP.
Hepatobiliary Pancreat Dis Int. 2011 Apr;10(2):128-35. doi: 10.1016/s1499-3872(11)60021-0.
PMID:21459718
Current State and Future Directions of Radiation Therapy for Pancreas Adenocarcinoma.
Gottumukkala S, Salamekh S, Sanford NN.
Surg Oncol Clin N Am. 2023 Jul;32(3):399-414. doi: 10.1016/j.soc.2023.02.001. Epub 2023 Apr 4.
PMID:37182984
A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.
Singhal R, Rogers SC, Lee JH, Ramnaraign B, Sahin I, Fabregas JC, Thomas RM, Hughes SJ, Nassour I, Hitchcock K, Russell K, Kayaleh O, Turk A, Zlotecki R, DeRemer DL, George TJ.
Future Oncol. 2023 Sep;19(27):1841-1851. doi: 10.2217/fon-2023-0256. Epub 2023 Sep 27.
PMID:37753702
The role of neoadjuvant therapy in pancreatic cancer: a review.
Russo S, Ammori J, Eads J, Dorth J.
Future Oncol. 2016 Mar;12(5):669-85. doi: 10.2217/fon.15.335. Epub 2016 Feb 1.
PMID:26880384
Management of urothelial cancer in patients with chronic kidney disease receiving platinum-based chemotherapy.
T O'Dwyer R, Jiang DM, Kitchlu A, Coulombe AM, Sridhar SS.
Future Oncol. 2024;20(36):2889-2899. doi: 10.1080/14796694.2024.2342227. Epub 2024 May 5.
PMID:38706176
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3